الفهرس | Only 14 pages are availabe for public view |
Abstract Laryngeal carcinoma account for almost one fourth of the approximately 45,000 head and neck malignancies diagnosed in 2007 in the United States, making laryngeal carcinoma one of the most common sites for head and neck cancer. Of these, approximately one half affect the true vocal folds. Supraglottic and glottic tumors are the most common subsites, and subglottic carcinomas are uniformly rare. In the United States, glottic carcinomas are the most common (glottic, 59%; supraglottic, 40%; subglottic, 1%). It is fortunate that even the earliest glottic cancer alters the voice by affecting wave pattern forms over the vocal cord, so even carcinoma in situ may produce significant voice change. The preoperative evaluation of patients with laryngeal carcinoma begins with a thorough history and physical examination in the office with subsequent endoscopy, surgical biopsy and imaging studies. The treatment of early glottic carcinoma is a topic of great importance and relevance. Glottic laryngeal squamous carcinoma in its early stages has an excellent prognosis. The disease can be effectively treated by external beam radiotherapy, conservative open laryngeal surgery or endoscopic resection. |